TOP STORIES

• BUSINESS Operating Profit Ratio for Pharmaceutical Wholesales at 0.32%, Improved but Still in Low Range: Top 4 Wholesalers
  May 15, 2012

• BUSINESS Midterm Plan to Overcome Generic Versions of Actos, Setting Sights on Emerging Markets: Takeda
  May 15, 2012

• REGULATORY Gov’t to Begin Operating “Drug Discovery Network” This FY with Initial Focus on Seeds for Anticancer Agents
  May 14, 2012

• BUSINESS The Growing Presence of Foreign-Affiliates (2)
  May 14, 2012

• BUSINESS “Figures to Look Forward to in 2013-2014” in Firm US Operations: President Teshirogi of Shionogi
  May 11, 2012

• BUSINESS Tenelia Planned to “Overwhelm Market with Power” in Alliance with Daiichi Sankyo: MTPC
  May 10, 2012

• ORGANIZATION Participation in TPP to Lead to Higher NHI Prices: JMA VP Nakagawa
  May 10, 2012

• BUSINESS Daiichi Sankyo Ties Up with Coherus BioSciences to Embark on Biosimilars Business
  May 9, 2012

• BUSINESS OrphanPacific Focuses on Building Detailing Form: President Ichikawa
  May 8, 2012

• BUSINESS DSP Aims to Enhance Its Presence in Field of Oncology by Developing First-in-Class Drugs
  May 7, 2012

• ACADEMIA St. Marianna University School of Medicine Hospital to Introduce CDTM, Protocols for Pharmacists to Determine Prescriptions
  April 27, 2012

• REGULATORY CSIMC to Establish Expert Subcommittee on Cost-Effective Assessments, 1st Meeting Scheduled in June
  April 26, 2012

• BUSINESS Generics Aimed for Early Stage Sales of 10 Billion Yen, in the Black for Establishing Base: Daiichi Sankyo Espha President Yoshiwaka
  April 25, 2012

• BUSINESS Astellas Senior VP Sato Shares Plans to Market Gonax Within Current Structure, MRs Dedicated to Cancer “a Future Issue”
  April 24, 2012

• BUSINESS Daiichi Sankyo Looking to Establish “Base Treatment” Position for Memary
  April 23, 2012

• ORGANIZATION JPMA Opposes Haste Adoption of Cost-Effective HTA
  April 20, 2012

• BUSINESS Takeda to Differentiate New ARB Azilva Stressing Its Strong Hypotensive Effects
  April 19, 2012

• BUSINESS JPWA, NPhA Agree to 6-Month Limit on Price Negotiations; Wholesalers’ Resolution to Be Tested for 3rd Time
  April 19, 2012

• REGULATORY Risk Management Plans to Be Required from April 2013 to Strengthen Post-Marketing Safety Measures
  April 18, 2012

• BUSINESS Eli Lilly Japan Pinning New Hopes on Solanezumab; Will the Introduction of Medicoeconomic Assessments Help?
  April 18, 2012

ページ

• « 先頭
• ‹ Prev
• …
• 232
• 233
• 234
• 235
• 236
• 237
• 238
• 239
• 240
• …
• Next ›
• 最終 »